Invention Application
WO2007031830A3 AN EXTRACT FROM XYLOCARPUS USEFUL FOR THE TREATMENT OF DIABETES AND DYSLIPIDEMIA
审中-公开
从XYLOCARPUS提取用于治疗糖尿病和DYSLIPIDEMIA
- Patent Title: AN EXTRACT FROM XYLOCARPUS USEFUL FOR THE TREATMENT OF DIABETES AND DYSLIPIDEMIA
- Patent Title (中): 从XYLOCARPUS提取用于治疗糖尿病和DYSLIPIDEMIA
-
Application No.: PCT/IB2006002462Application Date: 2006-09-07
-
Publication No.: WO2007031830A3Publication Date: 2007-07-12
- Inventor: LAKSHMI VIJAI , SAXENA AJET , KUMAR RAJESH , PAL RAGHWENDRA , SINGH SATYAWAN , SRIVASTAVA ARVIND KUMAR , TIWARI PREETI , RAINA DEEPAK , RASTOGI ANIL KUMAR , SRIVASTAVA SUDHIR , SRIVASTAVA MAHENDRA NATH , CHANDRA RAMESH , PURI ANJU , RAGHUBIR RAM , GUPTA POONAM , TADIGOPPULA NARENDER , TRIPATHI BRIJENDRA KUMAR
- Applicant: COUNCIL SCIENT IND RES , LAKSHMI VIJAI , SAXENA AJET , KUMAR RAJESH , PAL RAGHWENDRA , SINGH SATYAWAN , SRIVASTAVA ARVIND KUMAR , TIWARI PREETI , RAINA DEEPAK , RASTOGI ANIL KUMAR , SRIVASTAVA SUDHIR , SRIVASTAVA MAHENDRA NATH , CHANDRA RAMESH , PURI ANJU , RAGHUBIR RAM , GUPTA POONAM , TADIGOPPULA NARENDER , TRIPATHI BRIJENDRA KUMAR
- Assignee: COUNCIL SCIENT IND RES,LAKSHMI VIJAI,SAXENA AJET,KUMAR RAJESH,PAL RAGHWENDRA,SINGH SATYAWAN,SRIVASTAVA ARVIND KUMAR,TIWARI PREETI,RAINA DEEPAK,RASTOGI ANIL KUMAR,SRIVASTAVA SUDHIR,SRIVASTAVA MAHENDRA NATH,CHANDRA RAMESH,PURI ANJU,RAGHUBIR RAM,GUPTA POONAM,TADIGOPPULA NARENDER,TRIPATHI BRIJENDRA KUMAR
- Current Assignee: COUNCIL SCIENT IND RES,LAKSHMI VIJAI,SAXENA AJET,KUMAR RAJESH,PAL RAGHWENDRA,SINGH SATYAWAN,SRIVASTAVA ARVIND KUMAR,TIWARI PREETI,RAINA DEEPAK,RASTOGI ANIL KUMAR,SRIVASTAVA SUDHIR,SRIVASTAVA MAHENDRA NATH,CHANDRA RAMESH,PURI ANJU,RAGHUBIR RAM,GUPTA POONAM,TADIGOPPULA NARENDER,TRIPATHI BRIJENDRA KUMAR
- Priority: IN2464DE2005 2005-09-12
- Main IPC: A61K36/58
- IPC: A61K36/58 ; A61P3/06 ; A61P3/10
Abstract:
The present invention discloses a bioactive fraction obtained from Xylocarpus useful for the treatment of diabetes and dyslipidemia. Further, it relates to a pharmaceutical composition useful as antidiabetic and antidyslipidemic agent. The current embodiment also discusses to a method of treating diabetes and dyslipidemia in a subject. Further, the present invention relates to the novel isomeric xyloccensins and use thereof.
Information query
